Michelle Dipp, MD PhD is the co-founder and managing partner of Biospring Partners. She has a decade of experience in equity firm and venture capital for Life Sciences Technology companies.

Prior to co-founding Biospring Partners, Michelle served as managing director at General Atlantic, general partner of Longwood Fund, and SVP of the Center of Excellence for External Drug Discovery (CEEDD) for GlaxoSmithKline.

Biospring Partners is a private equity and venture capital firm that invests in growth-stage Life Sciences Technology companies. They help fund B2B enterprise software, tools, and services that help innovate businesses in the Life Sciences sector.